Log in

NYSEAMERICAN:AMPEAmpio Pharmaceuticals Stock Price, Forecast & News

$0.49
-0.01 (-2.01 %)
(As of 04/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$0.48
Now: $0.49
$0.53
50-Day Range N/A
52-Week Range
$0.26
Now: $0.49
$1.31
Volume1.71 million shs
Average Volume1.46 million shs
Market Capitalization$77.52 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of therapies for the treatment of prevalent inflammatory conditions in the United States. The company is developing compounds that decrease inflammation by inhibiting specific pro-inflammatory compounds. Its product pipeline includes Ampion, an intra-articular injection for the treatment of osteoarthritis of the knee. Ampio Pharmaceuticals, Inc. is headquartered in Englewood, Colorado.
Read More
Ampio Pharmaceuticals logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.18 out of 5 stars


Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Biotechnology
Sub-IndustryPharmaceuticals
SectorMedical
Current SymbolNYSEAMERICAN:AMPE
CUSIP03209T10
Phone+1-720-4376500

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees22
Market Cap$77.52 million
Next Earnings Date5/8/2020 (Estimated)
OptionableOptionable

Receive AMPE News and Ratings via Email

Sign-up to receive the latest news and ratings for AMPE and its competitors with MarketBeat's FREE daily newsletter.


Ampio Pharmaceuticals (NYSEAMERICAN:AMPE) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of Ampio Pharmaceuticals?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ampio Pharmaceuticals in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Ampio Pharmaceuticals.

When is Ampio Pharmaceuticals' next earnings date?

Ampio Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Friday, May 8th 2020. View our earnings forecast for Ampio Pharmaceuticals.

What price target have analysts set for AMPE?

1 Wall Street analysts have issued twelve-month price targets for Ampio Pharmaceuticals' shares. Their forecasts range from $4.00 to $4.00. On average, they anticipate Ampio Pharmaceuticals' stock price to reach $4.00 in the next year. This suggests a possible upside of 719.3% from the stock's current price. View analysts' price targets for Ampio Pharmaceuticals.

Has Ampio Pharmaceuticals been receiving favorable news coverage?

News headlines about AMPE stock have been trending very negative recently, InfoTrie reports. The research firm ranks the sentiment of media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Ampio Pharmaceuticals earned a news sentiment score of -3.3 on InfoTrie's scale. They also gave headlines about the specialty pharmaceutical company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the near term. View the latest news aboutAmpio Pharmaceuticals.

Who are some of Ampio Pharmaceuticals' key competitors?

What other stocks do shareholders of Ampio Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Ampio Pharmaceuticals investors own include Trevena (TRVN), Cerus (CERS), NovaBay Pharmaceuticals (NBY), Athersys (ATHX), AVEO Pharmaceuticals (AVEO), NVIDIA (NVDA), Rigel Pharmaceuticals (RIGL), Protalix Biotherapeutics (PLX), Arena Pharmaceuticals (ARNA) and Catalyst Pharmaceuticals (CPRX).

Who are Ampio Pharmaceuticals' key executives?

Ampio Pharmaceuticals' management team includes the following people:
  • Mr. Michael E. Macaluso, Founder, Chairman & CEO (Age 67)
  • Mr. Thomas E. Chilcott III, CFO, Treasurer & Sec. (Age 51)
  • Ms. Holli Cherevka, Chief Operating Officer (Age 36)

What is Ampio Pharmaceuticals' stock symbol?

Ampio Pharmaceuticals trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "AMPE."

How do I buy shares of Ampio Pharmaceuticals?

Shares of AMPE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Ampio Pharmaceuticals' stock price today?

One share of AMPE stock can currently be purchased for approximately $0.49.

How big of a company is Ampio Pharmaceuticals?

Ampio Pharmaceuticals has a market capitalization of $77.52 million. Ampio Pharmaceuticals employs 22 workers across the globe. View additional information about Ampio Pharmaceuticals.

What is Ampio Pharmaceuticals' official website?

The official website for Ampio Pharmaceuticals is http://ampiopharma.com/.

How can I contact Ampio Pharmaceuticals?

Ampio Pharmaceuticals' mailing address is 373 Inverness Pkwy Ste 200, ENGLEWOOD, CO 80112-5898, United States. The specialty pharmaceutical company can be reached via phone at +1-720-4376500.

This page was last updated on 4/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel